Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 6.0B | 6.4B | 6.9B | 6.5B |
Cost of revenue | 2.6B | 2.7B | 3.0B | 2.8B |
Gross profit | 3.3B | 3.7B | 3.9B | 3.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 575M | 664M | 536M | 590M |
Other operating expenses | — | — | — | — |
Operating income | 2.7B | 2.9B | 3.2B | 3.0B |
Non operating interest income | ||||
Income | 17M | 18M | 18M | 20M |
Expense | 376M | 380M | 381M | 373M |
Other income expense | 34M | 20M | -22M | -120M |
Pretax income | 2.3B | 2.5B | 2.8B | 2.6B |
Tax provision | 461M | 521M | 588M | 533M |
Net income | 1.9B | 2.0B | 2.3B | 2.0B |
Basic EPS | 2.6 | 2.8 | 3.2 | 2.8 |
Diluted EPS | 2.6 | 2.8 | 3.1 | 2.8 |
Basic average shares | 714.9M | 715.2M | 716.7M | 718.8M |
Diluted average shares | 718.2M | 719.7M | 720M | 722M |
EBITDA | 3.3B | 3.5B | 3.9B | 3.6B |
Net income from continuing op. | 1.9B | 2.0B | 2.3B | 2.0B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |